Breaking

What to expect as FDA advisory panel debates Pfizer COVID booster shots
Sep 17, 2021 40 secs
The group will discus and vote on whether to recommend Pfizer booster shots.

The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest data submitted by Pfizer and discuss whether a booster dose is safe enough for widespread use and whether it's necessary and effective at improving protection levels against COVID-19.

ET, followed by introductions by the FDA, presentations from CDC representatives, a discussion about booster protection and a presentation from Pfizer executives who will make the case for why boosters are appropriate.

Sharon Alroy Preis, who is set to present data on booster protection against COVID infection and severe disease.

Naming no one -- but nodding to those lingering concerns -- Pfizer's CEO Albert Bourla penned an open letter on Thursday making the case for booster shots.

RECENT NEWS

SUBSCRIBE

Get monthly updates and free resources.

CONNECT WITH US

© Copyright 2024 365NEWSX - All RIGHTS RESERVED